A phase 3, randomized, double-blind trial of nivolumab or nivolumab plus ipilimumab versus placebo in patients with localized renal cell carcinoma who underwent radical or partial nephrectomy and are at high risk of relapse (CheckMate 914)
Titel:
A phase 3, randomized, double-blind trial of nivolumab or nivolumab plus ipilimumab versus placebo in patients with localized renal cell carcinoma who underwent radical or partial nephrectomy and are at high risk of relapse (CheckMate 914)
Auteur:
Gruenwald, V. Bex, A. Russo, P. Tomita, Y. Simsek, B. Spiridigliozzi, J. Chudnovsky, A. Motzer, R.J.
Verschenen in:
European urology open science
Paginering:
Jaargang 33 () nr. S3 pagina's S331
Jaar:
2021
Inhoud:
Uitgever:
European Association of Urology. Published by Elsevier B.V.